We validated the heterogeneous expression of CD24, CD36 and CD302 in MM (Supplementary Figure 8) by real-time RT-PCR and flow cytometry (Supplementary Figures 3 and 4). This evidence concerns the gene CD302 and Miyoshi myopathy.